Emerging leader in cannabis infused beverages, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announced today that it has signed a Definitive Agreement (the “Agreement”) with high-profile cannabis operator company, Capna Intellectual, Inc. (“Capna”), to bring its leading multi-state cannabis vape brand, Bloom, to Canada. BevCanna will manufacture and sell Bloom branded products, including cannabis concentrates and extracts, in Canada. BevCanna will also acquire exclusive licensing and manufacturing rights to select product formats, technology and branding assets of Bloom. Bloom will be sold under the name “Cali-Bloom” in Canada to highlight the roots of the brand.
“We’re excited to bring the Bloom products to the Canadian market,” said John Campbell, Chief Strategic Officer at BevCanna. “Canadians are eager to see more vape options from trust-worthy retailers, and we’re happy to be able to provide that.”
“Canada has a rich history with cannabis and Canadians want vapes that match the experience of the smoking the plant. That’s what our [Bloom’s] goal is: deliver authentic cannabis experiences everywhere, every time,” said Vitaly Mekk, Chief Executive Officer of Capna Intellectual. Bloom products are currently sold in over three hundred retailers across five states: California, Nevada, New Mexico, Oklahoma, and Washington; and are available in leading retailers such as MedMen, Planet 13, Cookies, Caliva, and Connected.
“We’re also seeing great synergies between the two companies,” continued Mr. Campbell. “This agreement leverages BevCanna’s expertise in manufacturing infused cannabis products and Bloom’s reputation for creating safe, effective, appealing vapor cartridges and disposables. We’ve also discussed potential future opportunities to work together in other markets and product lines.”
Terms of the Definitive Agreement
The Agreement includes the following:
- BevCanna will manufacture, possess, and sell cannabis products, including cannabis concentrates and cannabis extracts, on behalf of Capna, as and when permitted by applicable Canadian regulations under a licence expected to be granted by Health Canada to the Company;
- Capna will grant an exclusive license to certain technology and branding assets to BevCanna in Canada in connection with the Company’s production of cannabis products for Capna;
- In the event that Capna decides to extend their products to beverage, BevCanna shall be the exclusive beverage manufacturer for Capna in Canada and will hold rights of first refusal to be the exclusive beverage manufacturer in any other U.S state or Europe;
- An initial term of 5 years, with automatic 5-year renewal periods, subject to a right of each party to terminate the Agreement if done at least 90 days prior to the expiry of the initial term or any renewal term;
- BevCanna has agreed to pay Capna a royalty payment of 38% of all net profits derived from the products subject to the Agreement; and
- Each party has agreed to contribute to marketing and branding costs.
- The Agreement is subject to the receipt by the Company of a license to be issued by Health Canada under the Cannabis Act (Canada)